Search clinical trials for: angiotensin converting enzyme inhibitor

Total 70515 results

Samaritan Pharmaceuticals, Inc

Unknown

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

HIV Infections | Human Immunodeficiency Virus

United States
Danish Headache Center

Terminated

PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers

Migraine | Headache

Denmark
University of Trieste

Unknown

Avastin for CNV Secondary to Pattern Dystrophy

Choroidal Neovascularization Secondary to Pattern Dystrophy

Italy
Ironwood Pharmaceuticals, Inc.

Completed

Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS

Irritable Bowel Syndrome

United States
Medical University of Vienna

Completed

Influence of Treatment With Olanzapine or Ziprasidone on Transcapillary Glucose Transport in Human Skeletal Muscle

Healthy Male Volunteers

Austria
National Center for Research Resources (NCRR)
Washington University School of Medicine; Janssen, LP

Unknown

Glucose Regulation During Risperidone and Olanzapine Treatment

Schizophrenia

United States
Eli Lilly and Company

Completed

Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents

Attention Deficit Hyperactivity Disorder

Sweden
Hamilton Health Sciences Corporation
AstraZeneca

Completed

Cognition, Functioning and Quality of Life

Schizophrenia

Canada
Avidia

Unknown

Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease

Crohn's Disease

Australia
Sankyo Pharma Gmbh

Completed

Olmesartan Medoxomil and Diabetic Nephropathy

Type 2 Diabetes Mellitus | Diabetic Nephropathy | Proteinuria | Renal Disease

Poland, Spain, Estonia, Czech Republic, Germany, Slovakia, Netherlands
Asan Medical Center

Unknown

Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy

Polypoidal Choroidal Vasculopathy

Korea, Republic of
University Of Perugia

Unknown

rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets

Intracerebral Hemorrhage

Italy
Lampiris, Harry W., M.D.
Abbott

Unknown

High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease

HIV | AIDS

United States
Sunnybrook Health Sciences Centre

Withdrawn

Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents

Major Depression

Canada
Weill Medical College of Cornell University
Forest Laboratories

Terminated

The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis

Depression | Multiple Sclerosis

United States
City Hospitals Sunderland NHS Foundation Trust
Takeda

Unknown

Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)

Cerebrovascular Accident | Acute Stroke

United Kingdom
Technische Universität Dresden

Completed

Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone.

Healthy Subjects

Germany
Dutch Epilepsy Clinics Foundation

Unknown

Second-Line Treatment Choice for Epilepsy

Adults With Tonic Clonic Seizures and/or Partial Seizures

Netherlands
University Hospital Tuebingen

Unknown

Below Study - Balloonangioplasty or Stents With ReoPro for Prevention of Subacute Reocclusion in Arteries Below the Knee

Patients Above 18 Years

Germany
University Hospital Tuebingen
University of Bern

Unknown

Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease

Arterial Occlusive Diseases

Germany
Hamilton Health Sciences Corporation
Eli Lilly and Company

Completed

Olanzapine in the Treatment of Hair Pulling (Trichotillomania)

Trichotillomania

Canada
University of Minnesota
AstraZeneca; Jensen, Jonathan B., M.D.

Completed

A Comparative Study of New Medications for Psychosis in Adolescents

Psychotic Disorders | Schizophrenia | Schizoaffective Disorders | Schizophreniform Disorders

United States
Gustave Roussy, Cancer Campus, Grand Paris
Hoffmann-La Roche

Unknown

Bevacizumab in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

France
Institute for Clinical Research

Unknown

Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS

Relapsing-Remitting Multiple Sclerosis

United States
Finnish Institute for Health and Welfare
Finnish Foundation for Alcohol Studies

Completed

Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.

Depression | Alcoholism

Finland
Sheba Medical Center
H. Lundbeck A/S

Unknown

Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia

Depressive Syndrome

Israel
Eli Lilly and Company

Completed

Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Canada
University Hospital, Lille

Completed

Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma

Multiple Myeloma

France
Pfizer

Completed

Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures

Pain
Huazhong University of Science and Technology

Unknown

Study of Optimal Treatment Plan in Hypertensives With Anti-AT1-Receptor Autoantibody

Hypertension

China
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women

HIV Infections | Pregnancy

United States, Puerto Rico
Shanghai Jiao Tong University School of Medicine

Completed

Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy

Diabetic Nephropathy | Type 2 Diabetes
University of California, San Francisco

Completed

Flushes and Sertraline Trial

Menopause-Hot Flashes

United States
Novartis

Completed

A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)

Hypertension

Switzerland
Abarbanel Mental Health Center

Completed

Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD)

Obsessive-Compulsive Disorder

Israel
Eli Lilly and Company
Boehringer Ingelheim

Completed

Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.

Stress Urinary Incontinence

United States
Pfizer
PPD

Completed

A First In Human Study Of PF-00184562 In Healthy Volunteers

Schizophrenia

United States
Eli Lilly and Company

Completed

Duloxetine in the Treatment of Melancholic Depression

Depressive Disorder, Major

Australia, Canada
Eli Lilly and Company

Completed

Switching to Duloxetine From Other Antidepressants

Major Depressive Disorder

Spain, France, Ireland, United Kingdom
Eli Lilly and Company

Completed

Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode

Bipolar Disorder

Spain
Eli Lilly and Company

Completed

Olanzapine in Patients With Borderline Personality Disorder

Borderline Personality Disorder

Germany, United States, Belgium, France, Norway, Portugal, Spain, Sweden, United Kingdom
Eli Lilly and Company

Completed

A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity

United States
Eli Lilly and Company

Completed

Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder

Borderline Personality Disorder

United States, Argentina, Poland, Romania, Turkey
Drug Commission of the German Medical Association
Madaus AG

Terminated

Cholesterol-Lowering Effects of Policosanol

Hypercholesterolemia | Combined Hyperlipidemia
Eli Lilly and Company

Completed

A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia

Schizophrenia

United States
Eli Lilly and Company

Completed

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

Depression | Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company

Completed

Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain

Depression | Pain

United States
Eli Lilly and Company

Completed

A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis

Sepsis

United States, Poland, Belgium, Netherlands, Hungary
Eli Lilly and Company

Completed

Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia

Schizophrenia

United States, United Kingdom, Spain, Argentina, Mexico, Brazil, Peru, Puerto Rico, Germany, Austria, Ireland, Venezuela
Eli Lilly and Company

Completed

Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder

Depressive Disorder

United States

Search clinical trials for: angiotensin converting enzyme inhibitor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations